Tech Company Financing Transactions
Perfinity Biosciences Funding Round
Perfinity Biosciences closed a $100 thousand funding round on 6/30/2012. Investors included CHV Capital.
Transaction Overview
Company Name
Announced On
6/30/2012
Transaction Type
Venture Equity
Amount
$100,000
Round
Undisclosed
Investors
CHV Capital (Matthew Neff)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1281 Win Hentschel Blvd.
West Lafayette, IN 47906
USA
West Lafayette, IN 47906
USA
Phone
Website
Email Address
Overview
The company is designing a method of preparing biological samples.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
General Manager
Joseph Chutka
President
Kevin Meyer
Browse more venture capital transactions:
Prev: 6/30/2012: Twin Creek Technologies venture capital transaction
Next: 6/30/2012: Diabetes Care Associates venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs